Andrew Einhorn joins Relief as chief financial officer (CFO). Mr. Einhorn brings extensive experience from senior leadership roles within clinical and commercial-stage life science companies. From ...

An update from RELIEF THERAPEUTICS Holding ( ($CH:RLF) ) is now available. Relief Therapeutics announced positive results from a pivotal ...

Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Relief Therapeutics Announces Executive Changes GENEVA (June 3, 2024) – ...

Relief Therapeutics has announced an extraordinary general meeting to seek shareholder approval for a business combination with NeuroX Group SA. The meeting will address proposals including a capital ...

GENEVA, SWITZARLAND / ACCESSWIRE / October 29, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF) (OTCQB: RLFTF) (OTCQB: RLFTY) (Relief, or the Company), a biopharmaceutical company committed to ...

GENEVA, SWITZERLAND / ACCESSWIRE / August 30, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...

GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering ...

Relief Therapeutics (OTCQB:RLFTY) Wednesday reported the formation of its new executive committee, with the appointment of several new members, including a chief financial officer, chief human ...

Relief Therapeutics (OTCQB:RLFTY) on Tuesday reported the execution of a binding term sheet for a proposed business combination with NeuroX Group SA, a privately held company that recently acquired ...

Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports In Vivo Data Published in the Peer Reviewed, International Journal of Molecular Sciences, Indicating Prolonged ...

GENEVA and LAUSANNE (Oct. 8, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief or the Company), a biopharmaceutical company committed to delivering innovative treatment ...

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE 29.10.2024 / 07:00 CET/CEST Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE GENEVA ...